Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05496985
Other study ID # YCYY-20211021-003
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 20, 2021
Est. completion date March 14, 2022

Study information

Verified date August 2022
Source Hangzhou Normal University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to translate the SECONDs from French into Chinese and assess the validity and reliability of the Chinese version of the SECONDs .


Description:

To promote accurate assessments of DoC patients and the development of clinical research on DoC in China, we here propose and validate a version of the SECONDs translated into Mandarin Chinese. Hence, this study aims to assess the concurrent validity (compared with the CRS-R which has already been translated and validated in Mandarin), intra-rater reliability, and inter-rater reliability of the Chinese version of the SECONDs


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date March 14, 2022
Est. primary completion date March 14, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days); - Age: 18-85 years old; - No history of other neurological or psychiatric deficits; - Ability to speak Chinese fluently; - Medical stability (e.g., absence of mechanical ventilation, sedation, infection) Exclusion Criteria: - None

Study Design


Intervention

Diagnostic Test:
Simplified Evaluation of CONsciousness Disorders (SECONDs)
All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)

Locations

Country Name City State
China International Vegetative State and Consciousness Science Institute, Hangzhou Normal University Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Hangzhou Normal University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assess the reliability and validity of the Chinese version of the SECONDs The reliability and validity of the Chinese version of the SECONDs were evaluated by calculating the weighted Cohen's Kappa and Spearman coefficients of the differences between SECONDs and CRS-R in the diagnosis of MCS and UWS patients Within 10 days
Primary Diagnose the level of consciousness in patients through SECONDs and CRS-R Detect acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days) patients through Simplified Evaluation of CONsciousness Disorders (SECONDs). Within 10 days
Primary Diagnose the level of consciousness in patients through CRS-R Detect acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days) patients through Coma Recovery Scale-Revised (CRS-R). Within 10 days
See also
  Status Clinical Trial Phase
Recruiting NCT05378035 - DOAC in Chinese Patients With Atrial Fibrillation
Completed NCT05080777 - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems N/A
Recruiting NCT06186024 - A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX N/A
Completed NCT06073145 - Transcranial Doppler Using Wearable Ultrasound Patch
Completed NCT03295786 - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease Phase 1/Phase 2
Recruiting NCT06010823 - Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Completed NCT02889939 - High-intensity Training in an Enriched Environment in Late Phase After Stroke N/A
Recruiting NCT05443542 - VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI N/A
Active, not recruiting NCT03911388 - HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors Phase 1
Completed NCT03994822 - pRESET for Occlusive Stroke Treatment N/A
Recruiting NCT06189950 - Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE N/A
Completed NCT04511546 - Exploratory Study Using a New Head-only PET Scanner N/A
Completed NCT04283253 - Predictors of Response in Chronic Stroke N/A
Recruiting NCT05578300 - Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
Completed NCT05815836 - Precision Medicine in Stroke
Completed NCT02776189 - Dexmedetomidine Verses Propofol for Paediatric MRI Brain Phase 4
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Recruiting NCT05048680 - Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly N/A